Catalog |
name |
Description |
price |
R-M2-9548 |
DMG-PEG-CD38 |
DMG-PEG-CD38/DMG-PEG-ARGDYYGSNSLDYW is a multifunctional conjugate that utilizes the benefits of lipid modification, PEGylation, and a targeting peptide sequence to improve the delivery of therapeutic agents. Targeting peptides, in particular, are powerful tools in modern therapeutic strategies, enabling the development of more effective and less toxic treatment options. Further development and optimization of this conjugate could advance its use in targeted drug delivery, diagnostic applications, or therapeutic innovations. |
price> |
R-M2-9555 |
DMG-PEG2000-WMVLPWLPGTLDGGSGCR |
DMG-PEG2000-WMVLPWLPGTLDGGSGCR is a multifunctional compound comprising PEG for improved pharmacokinetics, a DMG component for solubility and stability, and a specific peptide sequence for targeting or therapeutic action. This combination of elements makes it suitable for research and development in the fields of biomedicine, drug delivery, and peptide therapeutics. |
price> |
R-M2-9556 |
Chol-PEG2000-WMVLPWLPGTLDGGSGCR |
The Chol-PEG2000-WMVLPWLPGTLDGGSGCR compound is a versatile conjugate combining cholesterol, polyethylene glycol, and a peptide with potential applications in drug delivery, targeting, immunotherapy, and nanotechnology.The Chol-PEG2000 moiety in this conjugate may enhance the formulation’s ability to encapsulate hydrophobic drugs (due to the cholesterol) and improve solubility and circulation in biological systems (due to PEG). This conjugate could be particularly useful in liposomal formulations or micellar systems for drug delivery.The peptide sequence (WMVLPWLPGTLDGGSGCR) may act as a targeting ligand, allowing the conjugate to bind specifically to cell types, receptors, or tissues of interest. |
price> |
R-M2-9557 |
DMG-PEG2000-WEAALAEALAEALAEHLAEALAEALEALAA |
The DMG-PEG2000-WEAALAEALAEALAEHLAEALAEALEALAA compound is likely designed for use in advanced drug delivery systems or formulations aimed at improving the solubility, stability, and targeting capabilities of therapeutic agents. Its specific applications may span across targeted therapies, vaccine development, and potentially in creating multifunctional nanoparticles. |
price> |
R-M2-9558 |
Chol-PEG2000-WEAALAEALAEALAEHLAEALAEALEALAA |
Chol-PEG2000-WEAALAEALAEALAEHLAEALAEALEALAA is likely engineered for applications in drug and gene delivery systems while potentially providing targeted therapeutic capabilities. Its composition suggests enhanced biocompatibility and stability, as well as the capacity for specific cellular targeting due to the peptide inclusion. These properties make it suitable for diverse biomedical applications, including targeted therapies, vaccine development, and more. |
price> |
R-M2-9560 |
Chol-PEG2K-GPLVRG-mPEG5K |
Chol-PEG2K-GPLVRG-mPEG5K/Cholesterol-PEG2K-GPLVRG-mPEG5K/mPEG5K-GPLVRG-PEG2K-Chol could be designed to form nanoparticles for targeted drug delivery, especially for cancer or other therapies where increased specificity and reduced toxicity are desired. |
price> |
R-M1-8215 |
Cholesterol-PEG-FCIGRLGGGGGGC |
Cholesterol-PEG-FCIGRLGGGGGGC is a bifunctional peptide modified peg reagent. |
price> |
R-M1-8221 |
DMG-PEG2K-PKTRNSQTQTDRRRRRRRR |
DMG-PEG2K-PKTRNSQTQTDRRRRRRRR is a Peptide modified heterobifunctional peg reagent. |
price> |
R-M1-8246 |
c(RGDfK)-PEG2-MAL |
C(RGDfK)-PEG2-MAL is a cyclic peptide modified heterobifunctional peg reagent. |
price> |
R-M1-8247 |
mPEG2000-GPLGIAGQC |
MPEG2000-GPLGIAGQC is a single functionalized peg reagent modified with sequence peptides. |
price> |